Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME

被引：0

作者：

Toural, E. ^{[1
]}

Ridderstrale, M. ^{[2
]}

Fitchett, D. ^{[3
]}

Kis, S. Giljanovic ^{[4
]}

Woerle, H. -J. ^{[5
]}

Mattheus, M. ^{[5
]}

Zinman, B. ^{[6
,7
]}

Inzucchi, S. E. ^{[8
]}

机构：

[1] Ctr Salud Lavapies, Madrid, Spain

[2] Steno Diabet Ctr, Gentofte, Denmark

[3] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada

[4] Eli Lilly Suisse SA, Representat Off, Zagreb, Croatia

[5] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

[6] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

[7] Univ Toronto, Div Endocrinol, Toronto, ON, Canada

[8] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1130

引用

页码：S539 / S540

页数：2